NEU neuren pharmaceuticals limited

During the presentation was there any mention of the new...

  1. 594 Posts.
    lightbulb Created with Sketch. 74
    During the presentation was there any mention of the new indications and when they may be revealed? I presume that the seemingl acceptance of the "safety profile " of 2591 will carry over to these extra indications thus reducing the trial costs.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$16.63
Change
-0.070(0.42%)
Mkt cap ! $2.095B
Open High Low Value Volume
$16.68 $16.86 $16.51 $4.012M 240.7K

Buyers (Bids)

No. Vol. Price($)
2 982 $16.60
 

Sellers (Offers)

Price($) Vol. No.
$16.66 1000 1
View Market Depth
Last trade - 16.10pm 30/07/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.